# Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment

> **NCT03108209** · NA · COMPLETED · sponsor: **Michele Sayag** · enrollment: 30 (actual)

## Conditions studied

- Phototoxicity

## Interventions

- **OTHER:** Photoderm Max lait SPF50+
- **OTHER:** Photoderm Max Stick SPF50+

## Key facts

- **NCT ID:** NCT03108209
- **Lead sponsor:** Michele Sayag
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108209, "Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03108209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*